Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy

被引:1
作者
Kirakli, Esra Korkmaz [1 ]
Erdem, Sevilay [1 ]
Susam, Seher [2 ]
Erim, Eser [1 ]
机构
[1] Dr Suat Seren Chest Dis & Surg Res & Training Hos, Dept Radiat, Izmir, Turkiye
[2] Dr Suat Seren Chest Dis & Surg Res & Training Hos, Dept Radiol, Izmir, Turkiye
关键词
Ipsilateral lung dose; nonsmall cell lung cancer; radiation pneumonitis; radiochemotherapy; VOLUME HISTOGRAM PARAMETERS; REGIONAL DIFFERENCES; CANCER PATIENTS; PHASE-II; RADIOTHERAPY; TOXICITY; THERAPY; CHEMORADIATION; PREDICTION; CRITERIA;
D O I
10.4103/jcrt.jcrt_618_21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Mean lung dose (MLD) and percent of total lung (TL) volume that receive a dose greater than 20 Gy (V-20) have been the most validated parameters in the prediction of radiation pneumonitis (RP). However, these parameters present mean values of TL parenchyma and predict the right and the left lung as a unique functional organ unit, not take into account the difference in function and dose density between the lungs. Furthermore, there have been very limited data evaluating ipsilateral lung dosimetric constraints in addition to TL parameters to predict RP in non-small cell lung cancer (NSCLC) patients treated with radiochemotherapy (RCT). Methods: Between 2010 and 2017, clinical-radiological findings of NSCLC patients treated with RCT were evaluated in terms of RP, retrospectively. MLD, V-20, and V-30 values of ipsilateral lung were assessed from dose-volume histogram and registered. The primary endpoint was to assess the relation between ipsilateral lung dose constraints and RP risk. Results: There were 75 patients. There was >= Grade 2 RP in 33 cases (%44). In univariate analysis, ipsilateral MLD, ipsilateral V-20, ipsilateral V-30,V- and TL V-30 were found to be significant. Ipsilateral MLD and PTV were found to be the independent risk factors for RP. Cutoff values for RP risk were determined as 18Gy, 35%, and 28% for ipsilateral MLD, ipsilateral V-20, and ipsilateral V-30, respectively. Predictive values for ipsilateral MLD and ipsilateral V-20 were higher than TL. Conclusions: In NSCLC patients treated with RCT, MLD, V-20, and V-30 values of ipsilateral lung parameters might increase the predictability of RP risk in addition to TL parameters. Advances in Knowledge: Cutoff values for RP risk were determined as 18Gy, 35%, and 28% for ipsilateral MLD, ipsilateral V-20, and ipsilateral V-30, respectively. Predictive values for ipsilateral MLD and ipsilateral V-20 were higher than TL.
引用
收藏
页码:2023 / 1159
页数:7
相关论文
共 50 条
  • [31] Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy
    Wu, Kan
    Xu, Xiao
    Li, Xiadong
    Wang, Jiahao
    Zhu, Lucheng
    Chen, Xueqin
    Wang, Bing
    Zhang, Minna
    Xia, Bing
    Ma, Shenglin
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6531 - 6539
  • [32] Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters
    Zhou, Ying
    An, Tiansheng
    Zhou, Xiaojuan
    Caol, Peng
    Luol, Chunli
    Zhou, Lin
    Xu, Yong
    Liu, Yongmei
    Xue, Jianxin
    Wang, Jin
    Wang, Yongsheng
    Lu, You
    Liang, Binmiao
    Gong, Youling
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (06) : 505 - 514
  • [33] Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy
    Stoffers, Rutger H.
    Niezink, Anne G. H.
    Chouvalova, Olga
    Ubbels, Jan F.
    Woltman-van Iersel, Marleen
    Hiltermann, T. Jeroen N.
    Hijmering-Kappelle, Lucie B. M.
    Douma, Gea
    de Hosson, Sander M.
    van Putten, John W. G.
    Zandberg, Friso T.
    van Dijk, Lisanne V.
    Langendijk, Johannes A.
    Wijsman, Robin
    [J]. ACTA ONCOLOGICA, 2025, 64 : 267 - 275
  • [34] Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
    Deng, Yuxia
    Bian, Chao
    Tao, Hua
    Zhang, Haijun
    [J]. ONCOTARGET, 2017, 8 (45) : 79662 - 79669
  • [35] [18F]-FDG uptake dose response correlates with radiation pneumonitis in lung cancer patients
    McCurdy, Matthew R.
    Castillo, Richard
    Martinez, Josue
    Al Hallack, Mohammad Najeeb
    Lichter, Jessica
    Zouain, Nicolas
    Guerrero, Thomas
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 52 - 57
  • [36] A DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH STEREOTACTIC BODY RADIATION THERAPY
    Barriger, R. Bryan
    Forquer, Jeffrey A.
    Brabham, Jeffrey G.
    Andolino, David L.
    Shapiro, Ronald H.
    Henderson, Mark A.
    Johnstone, Peter A. S.
    Fakiris, Achilles J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 457 - 462
  • [37] Optimal Radiation Dose for Stage III Lung Cancer-Should "Definitive" Radiation Doses Be Used in the Preoperative Setting?
    Saffarzadeh, Areo G.
    Canavan, Maureen
    Resio, Benjamin J.
    Walters, Samantha L.
    Flores, Kaitlin M.
    Decker, Roy H.
    Boffa, Daniel J.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (08):
  • [38] Risk factors of radiation pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapy--Are we underestimating diabetes?--Turkish oncology group (TOG)/Lung cancer study group
    Ergen, Sefika A.
    Dincbas, Fazilet O.
    Yucel, Birsen
    Altinok, Pelin
    Akyurek, Serap
    Kirakli, Esra Korkmaz
    Ulger, Sukran
    Etiz, Durmus
    Yilmaz, Ufuk
    Kilic, Diclehan
    Bozcuk, Hakan
    [J]. CLINICAL RESPIRATORY JOURNAL, 2020, 14 (09) : 871 - 879
  • [39] Predictors of Radiation Pneumonitis and Associated Changes of Pulmonary Function After Definitive Concurrent Chemoradiotherapy in NSCLC
    Kim, Jae-Sung
    Park, Young Hee
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S689 - S689
  • [40] Exhaled nitric oxide predicts radiation pneumonitis in esophageal and lung cancer patients receiving thoracic radiation
    McCurdy, Matthew R.
    Wazni, Mohamad W.
    Martinez, Josue
    McAleer, Mary Frances
    Guerrero, Thomas
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 101 (03) : 443 - 448